{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:18:44Z","timestamp":1787242724008,"version":"build-2736575974"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>Acute myeloid leukemia (AML) is the most prevalent acute leukemia in adults. While conventional therapies can induce remission disease frequently relapses with fatal outcomes. This study aimed to explore the inhibitory effect of iron oxide nanoparticles (IONPs) combined with cytarabine (Ara-C) on AML by modulating the interferon-induced transmembrane protein 3 (IFITM3) expression of in KG-1a cells and AML-bearing mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A lentiviral vector targeting\n                      <jats:italic>IFITM3<\/jats:italic>\n                      (LV-shIFITM3) was used to transduce human AML KG-1a cells, and the biological effects of IFITM3 knockdown were assessed. NOD\/SCID mice were engrafted with LV-shIFITM3-KG1a cells and their survival status as well as abnormal cell population were monitored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to control cells, IFITM3 expression level in the LV-shIFITM3 transduced KG-1a cells exhibited reduced IFITM3 expression, leading to suppressed proliferation, impaired clonogenicity, cell cycle arrest, and increased apoptosis. The combination of IONPs and Ara-C further diminished IFITM3 level, inhibited KG-1a proliferation, and induced apoptosis while elevating reactive oxygen species (ROS) production.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , IONPs plus Ara-C treatment reduced immature granulocytes in peripheral blood and bone marrow, downregulated AML-associated markers (clustered differentiation(CD)33 and CD11b), and ameliorated disease progression in AML-bearing mice compared to controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IFITM3 knockdown in KG-1a cells inhibited proliferation and promoted apoptosis. The combination of IONPs and Ara-C may represent a promising therapeutic strategy for AML by suppressing IFITM3 expression, enhancing ROS levels, and inducing apoptosis. These findings suggest IFITM3 as a potential molecular target and highlight the synergistic efficacy of IONPs and Ara-C in AML treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1515956","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:14:05Z","timestamp":1756872845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["IONPs combined with cytarabine downregulated IFITM3 expression to inhibit acute myeloid leukemia"],"prefix":"10.3389","volume":"15","author":[{"given":"Jun","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kena","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61727-9","article-title":"Acute myeloid leukaemia in adults","volume":"381","author":"Ferrara","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1421816","article-title":"Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia","volume":"15","author":"Bian","year":"2024","journal-title":"Front Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0032-2","article-title":"Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs","volume":"11","author":"Meyers","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.143.12.3961","article-title":"IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells","volume":"143","author":"Jaffe","year":"1989","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1182005","article-title":"Interferon-induced transmembrane protein 3 in the hippocampus: a potential novel target for the therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy","volume":"16","author":"Li","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2.4.383","article-title":"Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control","volume":"2","author":"Levy","year":"1988","journal-title":"Genes Dev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.3.840","article-title":"A single DNA response element can confer inducibility by both alpha- and gamma-interferons","volume":"86","author":"Reid","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90270-8","article-title":"Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells","volume":"38","author":"Friedman","year":"1984","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/nano14151311","article-title":"Iron oxide nanoparticles as promising antibacterial agents of new generation","volume":"14","author":"Zhang","year":"2024","journal-title":"Nanomaterials (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S467733","article-title":"Fe(3)O(4)-coated CNTs-gum arabic nano-hybrid composites exhibit enhanced anti-leukemia potency against AML cells via ROS-mediated signaling","volume":"19","author":"Abdel Halim","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2012.02.015","article-title":"Nanoparticle-based adjuvant for enhanced protective efficacy of DNA vaccine Ag85A-ESAT-6-IL-21 against Mycobacterium tuberculosis infection","volume":"8","author":"Yu","year":"2012","journal-title":"Nanomedicine"},{"key":"B13","article-title":"Isolation and identification of cancer stem-like cells from murine melanoma cell lines","volume":"4","author":"Dou","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e3182a5e760","article-title":"Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells","volume":"23","author":"Chen","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"114547","DOI":"10.1016\/j.biopha.2023.114547","article-title":"Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination","volume":"161","author":"Xu","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.03.013","article-title":"Reinforcing B16F10\/GPI-IL-21 vaccine efficacy against melanoma by injecting mice with shZEB1 plasmid or miR200c agomir","volume":"80","author":"Wang","year":"2016","journal-title":"BioMed Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S278885","article-title":"Iron oxide nanoparticles combined with cytosine arabinoside show anti-leukemia stem cell effects on acute myeloid leukemia by regulating reactive oxygen species","volume":"16","author":"Dou","year":"2021","journal-title":"Int J Nanomedicine"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1515956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:14:06Z","timestamp":1756872846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1515956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":17,"alternative-id":["10.3389\/fonc.2025.1515956"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1515956","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1515956"}}